What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Stock Thread (24 Viewers)

Sens Warren and Sanders slam Trump for giving Gilead Windfall deal for coronavirus drug

“Outside analysts have concluded that ‘The deal is amazingly good for Gilead’s executives and shareholders and amazingly bad for everyone else—bad for taxpayers, terrible for public health, and unethical,’” the lawmakers wrote in the later dated Thursday.

Gilead said it would sell remdesivir for $520 per vial in the U.S. to patients with private insurance and $390 per vial to federal insurance programs like Medicare as well as foreign countries. The majority of patients treated with remdesivir receive a five-day treatment course using six vials of remdesivir, the company said. That would bring the cost to $2,340 for foreign and U.S. Medicare patients and $3,120 for U.S. patients with private health coverage.

That means Gilead is charging “American health insurers the highest prices in the world,” the senators wrote. 
I don't want to pay $3,120 for remdesivir to just potentially reduce my recovery time by 20%.  

When HHS Secretary Alex Azar announced the agreement last month, he called it “an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19. To the extent possible, we want to ensure that any American patient who needs remdesivir can get it.”

He said the administration “is doing everything in our power to learn more about life-saving therapeutics for COVID-19 and secure access to these options for the American people.”
Everything in their power to secure access to life-saving therapeutics for the american people.  Ok.  Hopefully they'll get good news on a new upstart drug in the next couple of weeks. 

 
Last edited by a moderator:
Today seems to be repeating yesterday's midday sideways movement for CYDY.  If there isn't a lunchtime short attack, there is probably a good chance the stock rises over the last 90 minutes again today.  It could be a savvy day trade.
I am considering it 

 
Confessional time: I just sold 40% of $CYDY, but it’s not really as bad as that statement reads.  I had whatever amount invested That I felt comfortable with.  When it dropped to $2.90 I doubled down plus a smidge.

had a good look at the big picture this morning and came to the conclusion if we get some bad news I’d really really hate myself for being overexposed.

im back to the “nice sized but not obscene” amount invested and increased the amount of shares as my price per share dropped.  that’s a good thing.

im going to sleep at night either way.  When this goes to $50 I’ll still be rich.
 
This is the way to do it. The correct process, if you will. Some of the others may still get a great result if CYDY goes to the moon, but the process should be to take the 5-bagger or 10-bagger when you can. 

 
Thanks. I’ve done my research and am going to invest heavily into the ETF named ANGL. It has a dividend yield of 5.72%. It’s comprised of “Fallen Angel” bonds that have been recently downgraded from investor grade to junk grade. Core holdings are companies like Sprint, Kraft Heinz, Newell Brands, Freeport McMoran, etc. Companies that yes have had some tough times but I don’t see them defaulting and vanishing overnight. This seems like free 5+% profit. As old bonds mature, they add select new “angel” items. 💰 💰 💰 💵 💵 💵 chet chet chet  
Just an update that I've been very happy with this investment so far. ANGL is up around 2% since I bought in. I got in just after the last dividend, but am looking forward to the juicy monthly dividends coming up. Yield is around 5.72%. Just a heads up if anyone is looking for a good dividend paying ETF.  Seems to me to be a nice risk/reward addition to a well balanced portfolio.

 
What they weren't able to do is exclude people based on comorbidities such as diabetes or heart disease, because that would probably knock out too many of their actual severe patient population.
Thanks for your thoughts.  I don't think they wanted to exclude people with those co-morbidities because those patients have such incredibly strong anecdotal data from the EINDs.

 
Bought some more Sea limited this morning, up a little now. 

With Fidelity rules, I'll need to hold a few days. Don't know if I'd sell anyway.

 
Bought some more Sea limited this morning, up a little now. 

With Fidelity rules, I'll need to hold a few days. Don't know if I'd sell anyway.
Took my 2% profit and called today a success.  Went heavier in LVGO than SE anyway.

 
Thanks for your thoughts.  I don't think they wanted to exclude people with those co-morbidities because those patients have such incredibly strong anecdotal data from the EINDs.
Yeah, that can actually become quite a positive for them as well. If you have broader inclusion and narrower exclusion criteria, then that means you are willing to take on riskier sub-populations within an already risky group. Then if you show that mortality benefit in that scenario it helps wipe away more questions that could remain. I didn't mean the comment as a critique in any way, but upon re-reading could see that maybe could be interpreted that way. They need those populations in there from a practical (enrollment) standpoint as well as aspirational (proof of efficacy) one.

 
Trimmed some LVGO that bounced nicely for $99.xx to $103.40.  Keep half of the new shares looking for a higher exit.

Sold 90% of my pre-market BCQ addition for a 1-1.5% gain.  It didn't move the way I expected so taking that profit.  I'm still holding my long term shares.

cydy limit orders at $5.25 and $5.15 tripped.  Missed on the $5.05 (that seems to be a theme with this stock so I will set them at .x6 going forward.  I had them in place at 10 cent increments all the way down to $4.45.  This seems to be the only way to pick up cheap shares as the drops are swift and rebounds immediate.

 
Trimmed some LVGO that bounced nicely for $99.xx to $103.40.  Keep half of the new shares looking for a higher exit.

Sold 90% of my pre-market BCQ addition for a 1-1.5% gain.  It didn't move the way I expected so taking that profit.  I'm still holding my long term shares.

cydy limit orders at $5.25 and $5.15 tripped.  Missed on the $5.05 (that seems to be a theme with this stock so I will set them at .x6 going forward.  I had them in place at 10 cent increments all the way down to $4.45.  This seems to be the only way to pick up cheap shares as the drops are swift and rebounds immediate.
I put in a limit buy at $4.20 just in case it drops that far. Puff, puff, pass. 

 
You guys read any of the #### on investor boards about Cytodyn? 

That kind of #### makes me want to sell so bad. The majority of the people who are long there, they're the dumbest mother####ers on Earth with the #### they write. It frightens me being on the same side as some of them. 

Devil's Advocatel; there are some equally stupid shorts. 

 
Thoughts on GILD?  I bought over the last month and it's been flat to down.  I'm reading all these articles how Trump is filling their coffers with money, but it's not reflecting in the stock price.  Hold or Sell?

 
You guys read any of the #### on investor boards about Cytodyn? 

That kind of #### makes me want to sell so bad. The majority of the people who are long there, they're the dumbest mother####ers on Earth with the #### they write. It frightens me being on the same side as some of them. 

Devil's Advocatel; there are some equally stupid shorts. 
Atleast the shorts are funny sometimes.  The longs are just pathetic.

 
Thoughts on GILD?  I bought over the last month and it's been flat to down.  I'm reading all these articles how Trump is filling their coffers with money, but it's not reflecting in the stock price.  Hold or Sell?
It doesn't reflect in their stock price bc A) they have nothing new and exciting on the horizon B) everyone knows Remdisivir is useless C) Their HIV franchise only has so much time left, which goes back to A. 

 
LVGO now in the double digit price.
I’d love to see it drop more to add to my 100 shares. I should have just bought in the 20s. Still a tiny bit annoyed I didn’t go all in back in March. Let the fear of another drop cloud the easy decision just based on price.

I’d love to add some more in the 70/80s but that would likely mean a real bad dip overall. Probably should have just bought a large share at $59. I think it’ll be huge long term.

 
You guys read any of the #### on investor boards about Cytodyn? 

That kind of #### makes me want to sell so bad. The majority of the people who are long there, they're the dumbest mother####ers on Earth with the #### they write. It frightens me being on the same side as some of them. 

Devil's Advocatel; there are some equally stupid shorts. 
Incredibly bad.  95% of posts from either side are ridiculous.  Some decent ones sprinkled in among the absurd.  

 
I’d love to see it drop more to add to my 100 shares. I should have just bought in the 20s. Still a tiny bit annoyed I didn’t go all in back in March. Let the fear of another drop cloud the easy decision just based on price.

I’d love to add some more in the 70/80s but that would likely mean a real bad dip overall. Probably should have just bought a large share at $59. I think it’ll be huge long term.
I didn't get started until the 70-80s.  Been trading shares to essentially reduce the basis of my initial buys by about $20 to date.  I'm still sitting on 20-25% cash waiting for better buying days.  Anyway, great tip on your part....thanks.

 
There was some discussion last night as to how good the CYDY severe-critical study has to be to be statistically significant.

Here's a link to a calculator.

Not sure I did this correctly, but I used a trial size of 90 with 12 deaths in both placebo and drug arms which translated into the following inputs:

Hypothesized Parameter 0

First Sample Size 30

First sample proportion 0.6

Second Sample Size 60

Second Sample Proportion 0.8

This results in a p-value of 0.0264 which makes it lower than 0.05 and significant.

 
Last edited by a moderator:
You guys read any of the #### on investor boards about Cytodyn? 

That kind of #### makes me want to sell so bad. The majority of the people who are long there, they're the dumbest mother####ers on Earth with the #### they write. It frightens me being on the same side as some of them. 

Devil's Advocatel; there are some equally stupid shorts. 
On the yahoo board there is literally one guy whose posts I seek out. Somebody named “thoughtful investor” and this time the username really checks out. Rest of that board is a hellhole. 

 
Think they'll announce they unblinded the results over the weekend, my guess. Maybe overnight tonight, but I'm doubtful... Hopefully they don't #### this up somehow. Results next Friday, possibly over next weekend. Going to be a wild week. 

 
Think they'll announce they unblinded the results over the weekend, my guess. Maybe overnight tonight, but I'm doubtful... Hopefully they don't #### this up somehow. Results next Friday, possibly over next weekend. Going to be a wild week. 
What's the likelihood trading indications in advance will be able to tip us off on the results?

 
On the yahoo board there is literally one guy whose posts I seek out. Somebody named “thoughtful investor” and this time the username really checks out. Rest of that board is a hellhole. 
investorhangout the best imo.  not to be mistaken with investorhub which is a bit more spammy

 
There was some discussion last night as to how good the CYDY severe-critical study has to be to be statistically significant.

Here's a link to a calculator.

Not sure I did this correctly, but I used a trial size of 90 with 12 deaths in both placebo and drug arms which translated into the following inputs:

Hypothesized Parameter 0

First Sample Size 30

First sample proportion 0.6

Second Sample Size 60

Second Sample Proportion 0.8

This results in a p-value of 0.0264 which makes it lower than 0.05 and significant.
Is 90 how many they have enrolled in that study so far? Saw they are looking for 390 total.

 
Is 90 how many they have enrolled in that study so far? Saw they are looking for 390 total.
There are more enrolled but I don't know how many they are planning to submit for a safety check.

Any thoughts on where the p-value needs to be to have the FDA halt and approve?

 
This popped up in news on Thinkorswim, I assumed it came out today -

Penn National Gaming (NASDAQ:PENN) reported Q1 sales of $1.12 billion but lost a total of $608.60 million in terms of earnings, which is a 187.33% decrease from last quarter. Penn National Gaming reached earnings of $696.90 million and sales of $1.34 billion in Q4.

What Is Return On Capital Employed?

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed in a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth in a company and is a sign of higher earnings per share for shareholders in the future. A low or negative ROCE suggests the opposite.

In Q1, Penn National Gaming posted a ROCE of -0.33%.
Where would that come from when they are supposed to announce in August?

 
Think they'll announce they unblinded the results over the weekend, my guess. Maybe overnight tonight, but I'm doubtful... Hopefully they don't #### this up somehow. Results next Friday, possibly over next weekend. Going to be a wild week. 
It will be tonight or tomorrow after the bell.

the interesting part will be if the say they unblinded but give no comments beyond that fact.

I seem to recall them saying it would be unblinded this week for sure and then at the end of it NP quipped “it might be Friday but it’s this week”.

 

Users who are viewing this thread

Back
Top